文献速递胸部心血管MR

慢性阻塞性肺疾病中的肺动脉僵硬度增加及其对右心室重构的意义

Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling.
PubMed 文献 · Eur Radiol · 2018-02-27

研究对58例COPD患者和21名健康对照行心脏MRI测量肺动脉脉搏波速度(PWV)及右心室参数,COPD组PWV升高、右心室舒张末期容积和每搏量降低,PWV与右心室参数无关联;结论认为COPD右心室重构更符合充盈减少而非后负荷增加。

要点

  • COPD患者肺动脉PWV较健康对照升高(2.62±1.29 ms-1 vs 1.78±0.72 ms-1,p=0.001)。
  • COPD患者右心室舒张末期容积和每搏量较健康对照降低,而右心室质量无差异。
  • 肺动脉PWV与右心室参数无关联。

核心结论

  • COPD患者存在肺血管重构,但心脏重构更倾向于充盈减少而非后负荷增加;对多数COPD患者,治疗阻塞性肺疾病对心功能的影响可能大于治疗肺血管疾病。

研究设计与样本

  • 研究纳入58例COPD患者(行肺功能检查、6分钟步行试验和心脏MRI)和21名健康对照(仅行心脏MRI),其中32例COPD患者接受随访MRI评估右心室指标纵向变化;采用心脏MRI定量右心室质量、容积和PWV。

关键影像表现/征象

  • COPD组肺动脉搏动性较健康对照降低(24.88±8.84% vs 30.55±11.28%,p=0.021)。
  • COPD组肺动脉加速时间较健康对照缩短(104.0±22.9 ms vs 128.1±32.2 ms,p<0.001)。
  • COPD组肺动脉PWV较健康对照升高(2.62±1.29 ms-1 vs 1.78±0.72 ms-1,p=0.001)。
  • COPD组右心室舒张末期容积较健康对照降低(53.6±11.1 ml vs 59.9±13.0 ml,p=0.037)。
  • COPD组右心室每搏量较健康对照降低(31.9±6.9 ml/m2 vs 37.1±6.2 ml/m2,p=0.003),右心室质量无差异(p=0.53)。

诊断标准与关键数值

  • COPD组与健康对照组的连续变量差异采用独立t检验,PWV与右心室参数的关联采用Pearson相关系数分析。

临床应用与阅片要点

  • 心脏MRI可无创测量肺动脉PWV,用于评估COPD患者的肺动脉僵硬度。
  • COPD患者右心室重构表现为舒张末期容积和每搏量降低而质量无差异,解读时需注意与后负荷增加所致重构相鉴别。
  • 本研究中肺动脉PWV与右心室参数无关联,提示肺动脉僵硬度增加未必直接导致右心室重构。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Pulmonary pulse wave velocity (PWV) allows the non-invasive measurement of pulmonary arterial stiffening, but has not previously been assessed in COPD. The aim of the current study was to assess PWV in COPD and its association with right ventricular (RV) remodelling.

METHODS: Fifty-eight participants with COPD underwent pulmonary function tests, 6-min walk test and cardiac MRI, while 21 healthy controls (HCs) underwent cardiac MRI. Thirty-two COPD patients underwent a follow-up MRI to assess for longitudinal changes in RV metrics. Cardiac MRI was used to quantify RV mass, volumes and PWV. Differences in continuous variables between the COPD and HC groups was tested using an independent t-test, and associations between PWV and right ventricular parameters was examined using Pearson's correlation coefficient.

RESULTS: Those with COPD had reduced pulsatility (COPD (mean±SD):24.88±8.84% vs. HC:30.55±11.28%, p=0.021), pulmonary acceleration time (COPD:104.0±22.9ms vs. HC: 128.1±32.2ms, p<0.001), higher PWV (COPD:2.62±1.29ms-1 vs. HC:1.78±0.72ms-1, p=0.001), lower RV end diastolic volume (COPD:53.6±11.1ml vs. HC:59.9±13.0ml, p=0.037) and RV stroke volume (COPD:31.9±6.9ml/m2 vs. HC:37.1±6.2ml/m2, p=0.003) with no difference in mass (p=0.53). PWV was not associated with right ventricular parameters.

CONCLUSIONS: While pulmonary vascular remodelling is present in COPD, cardiac remodelling favours reduced filling rather than increased afterload. Treatment of obstructive lung disease may have greater effect on cardiac function than treatment of pulmonary vascular disease in most COPD patients KEY POINTS: • Pulmonary pulse wave velocity (PWV) is elevated in COPD. • Pulmonary PWV is not associated with right ventricular remodelling. • Right ventricular remodelling is more in keeping with that of reduced filling.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Weir-McCall JR, Liu-Shiu-Cheong PS, Struthers AD, et al. Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling. Eur Radiol. 2018. PMID: 29488084. doi:10.1007/s00330-018-5346-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。